|
Market Closed -
Sao Paulo
22:28:29 25/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 81.36 BRL | +0.82% |
|
+2.86% | +23.35% |
| 08-21 | FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case | DJ |
| 08-20 | Piper Sandler Adjusts Price Target on Amgen to $457 From $427, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | +0.82% | +2.86% | +23.35% | +45.68% | +97.00% | 239B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN34 Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
